Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3320-3323, September 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, F. F.

Inhibition of Spontaneous Hepatocarcinogenesis in C3H/HeN Mice by Transplanted Hepatocellular Carcinomas1

Frederick F. Becker

Section of Experimental Pathology, Department of Pathology, The University of Texas System Cancer Center, Houston, Texas 77030

Cell suspensions of tumor fragments derived from spontaneous or chemically induced primary hepatocellular carcinomas obtained from inbred C3H/HeN mice were transplanted into young male mice of the same strain. Transplantable hepatocellular carcinomas were excised as soon as they were detected, and all recipient mice were killed at one year of age. In control C3H/HeN mice, the incidence of primary hepatocellular carcinomas was 41% (41 of 100). In mice in which there was no growth of transplantable carcinomas, whether originally given injections of tumor cell suspensions or fragments, the overall incidence of primary hepatocellular carcinomas was 49% (35 of 72) with one to six tumors per liver at time of sacrifice. Transplantable hepatocellular carcinomas were established only in mice that had received tumor fragments. In these mice, from which established transplantable hepatocellular carcinomas had been excised, the overall incidence of primary hepatocellular carcinomas was 12% (3 of 25) with one tumor being found in each of three livers. The time of appearance or excision of transplantable hepatocellular carcinoma did not affect this decrease in primary hepatocellular carcinoma incidence.

1 This investigation was supported in part by Contract CP65846 and Grant CA20659 awarded by the National Cancer Institute, Department of Health and Human Services.

Received 6/18/80. Accepted 5/20/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.